SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments???
BSX 98.84+0.3%Nov 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OldAIMGuy who wrote (766)7/19/2001 12:13:32 PM
From: Lighthouse  Read Replies (1) of 798
 
BSX trying to crawl out of the swamp in the 2nd QTR.

Tobin's blocking & tackling grades (author's own misguided opinion only). I say this because it is my opinion that Tobin's job is to make BSX a self-sustaining, leading, mature acting, medical products comnpany.

Sales = B- (Not too bad considering stent sales slid so much)
COGS reduction/ Gross Margin enhancement = B
R&D expenses (way up in Q2) = B+
SG&A costs = C-
Balance Sheet Management = B+
Tie in Acquisition = {A little early to grade here)
Medinol mess = D Fish or cut bait with these guys. IMHO walk away.

BSX is making a large trun for the better. Unfortunately during the heyday M&A days people forgot about continual R&D in house innovation, balance sheet management, and other house cleaning chores. The Medinol mess was symptomatic of a company trying to offer a suite of products in a very rapid time frame. Mistakes were made and the company is paying them now.

Progress is being made. The light at the end of the tunnel is coated stents. BSX is in the second position currently. If data from the JNJ and BSX trials continues to be as good as it has been, then coated stents will make a very rapid intro into the market. GDT and MDT are behind and they know it.

Cheers,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News